Xarelto Purposely Pushed to Market Regardless of Dangers
This is Michael Brady Lynch, Lead Trial Attorney for The Michael Brady Lynch Firm.
The truth is coming to light as reports surface which proves Xarelto manufacturers, Johnson & Johnson and Bayer knew the deadly blood-thinner was too dangerous to be on the market. Yet, they did nothing to protect the American consumer. Instead, they lied about data in a clinical trial. They were dishonest to get Xarelto FDA approval quickly.
During the ROCKET AF clinical trial, which helped gain FDA approval of Xarelto, Johnson & Johnson purposely withheld data about the problem associated with a medical device, INRation, which monitored patients using warfarin during a phase of the trial. This device was misleading results and said Xarelto was more effective than tried and true warfarin. Johnson & Johnson even went so far as to claim that it reduced stroke by 35%. These results were so significant, that it helped the FDA fast-track Xarelto to approval.
Now, internal documents from doctors conducting the trial have surfaced. These documents outline personal reservations about the legitimacy of it. Researchers mainly used the blood monitor. They felt it is was malfunctioning and not showing accurate numbers. This caused many doctors to incorrectly prescribe the dosage amounts in the warfarin phase of the trial. This may have led to additional bleeding episodes that gave Xarelto the edge in the study.
The personal information of the doctors who questioned the authenticity of the ROCKET AF trial had been redacted by Bayer. Now, US District Court Judge Eldon Fallon ordered Bayer to release to the court the redacted personnel records of these doctors. They will be called to testify. This will prove in open court that Xarelto was in fact rushed to market on deadly misinformation.
These manufacturers killed over a thousand people and harmed tens of thousands by skewing the trial results. The FDA approved Xarelto without an antidote. This led to many experiencing uncontrollable bleeding with few options for doctors to treat it. Xarelto prevents clotting, so many were left with organs rapidly losing some or all of its functionality while pools of blood formed within their bodies.
These pharmaceutical corporations will keep pushing these drugs to market ahead of the safety measures needed for their profits over the American consumer. Xarelto made close to $2 billion last year alone. The fact that the effects of these drugs are devastating makes no difference.
At The Michael Brady Lynch Firm, we take these bleeding side effects very seriously, and we fight to make sure that pharmaceutical companies understand the seriousness as well. If you or a loved one have experienced a bleeding event from taking Xarelto or Pradaxa I urge you to contact us at 877-513-9517. Let us fight for you.